Therapeutic agents useful for treating pain

Details for Australian Patent Application No. 2008246202 (hide)

Owner Purdue Pharma L.P.

Inventors Tafesse, Laykea

Agent FB Rice

Pub. Number AU-B-2008246202

PCT Pub. Number WO2008/133973

Priority 60/924,056 27.04.07 US; 60/924,377 11.05.07 US

Filing date 25 April 2008

Wipo publication date 6 November 2008

Acceptance publication date 1 December 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/133973 Priority application(s): WO2008/133973

1 December 2011 Application Accepted

  Published as AU-B-2008246202

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008246203-Vacuum gripping apparatus

2008246195-Methods of reducing nephrotoxicity in subjects administered with nucleoside